Physiology of Activins/Follistatins: Associations With Metabolic and Anthropometric Variables and Response to Exercise
Open accessThe DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Abstract
Context: Clinical trials are evaluating the efficacy of inhibitors of the myostatin pathway in neuromuscular and metabolic diseases. Activins and follistatins are major regulators of the myostatin pathway, but their physiology in relation to metabolic and anthropometric variables and in response to exercise remains to be fully elucidated in humans. Objective: We investigated whether concentrations of circulating activin A, activin B, follistatin, and follistatin-like 3 (FSTL3) are associated with anthropometric and metabolic variables and whether they are affected by exercise. Design: Activin A, activin B, follistatin, and FSTL3 were measured in (1) 80 subjects divided according to age (young vs old) and fitness status (active vs sedentary) before and after exercise at 70% maximal oxygen consumption (VO2max), followed by 90% of VO2max until exhaustion; and (2) 23 subjects [9 healthy and 14 with metabolic syndrome (MetS)] who completed four sessions: no exercise, high-intensity interval exercise, continuous moderate-intensity exercise, and resistance exercise for up to 45 minutes. Results: At baseline, follistatin and FSTL3 concentrations were positively associated with age, fat percentage, and body mass index (P < 0.001). Follistatin was positively associated with serum cholesterol (P = 0.005), low-density lipoprotein cholesterol (P = 0.01), triglycerides (P = 0.033), and blood pressure (P = 0.019), whereas activin A and activin B were higher in physically active participants (P = 0.056 and 0.029, respectively). All exercise types increased the levels of all hormones ∼10% to 21% (P = 0.034 for activin B, P < 0.001 for the others) independent of the presence of MetS. Conclusion: Concentrations of circulating activins and follistatins are associated with metabolic parameters and increase after 45 minutes of exercise.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Follistatin originates from the liver and rises when the glucagon-to-insulin ratio increases in the case of fasting and aerobic and resistance exercise [74].”
From Adipokines, Myokines, and Hepatokines: Crosstalk and Metabolic Repercussions (2021) · cites this paper as [74]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In humans, circulating follistatin is primarily derived from the liver and, similar to FGF21 and ANGPTL4, increases in response to an augmented glucagon-to-insulin ratio in conditions such as fasting and exercise, including HIIT, continuous aerobic, and resistance modalities [182,198].”
From The Role of Exercise in the Interplay between Myokines, Hepatokines, Osteokines, Adipokines, and Modulation of Inflammation for Energy Substrate Redistribution and Fat Mass Loss: A Review (2020) · cites this paper as [182]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Calculation of percentage changes in volumes of blood, plasma, and red cells in dehydration.
Dill, D. B., & Costill, D. L. (1974) · Journal of Applied Physiology · doi:10.1152/jappl.1974.37.2.247 · Cited by 3,384
Muscles, exercise and obesity: skeletal muscle as a secretory organ
Pedersen, B. K., & Febbraio, M. A. (2012) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2012.49 · Cited by 2,909
Muscle wasting in disease: molecular mechanisms and promising therapies
Cohen, S., Nathan, J. A., & Goldberg, A. L. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4467 · Cited by 1,089
A phase I/IItrial of MYO‐029 in adult subjects with muscular dystrophy
Wagner, K. R., Fleckenstein, J. L., Amato, A. A., Barohn, R. J., Bushby, K., Escolar, D. M., Flanigan, K. M., Pestronk, A., Tawil, R., Wolfe, G. I., et al. (2008) · Annals of Neurology · doi:10.1002/ana.21338 · Cited by 481
Strength Training with Blood Flow Restriction Diminishes Myostatin Gene Expression
LAURENTINO, G. C., UGRINOWITSCH, C., ROSCHEL, H., AOKI, M. S., SOARES, A. G., NEVES, M., AIHARA, A. Y., DA ROCHA CORREA FERNANDES, A., & TRICOLI, V. (2012) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0b013e318233b4bc · Cited by 464
Huh, J. Y., Mougios, V., Kabasakalis, A., Fatouros, I., Siopi, A., Douroudos, I. I., Filippaios, A., Panagiotou, G., Park, K. H., & Mantzoros, C. S. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-1437 · Cited by 363
Self-citationExercise-induced myokines and their role in chronic diseases
Pedersen, B. K. (2011) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2011.02.010 · Cited by 362
Myostatin/activin pathway antagonism: molecular basis and therapeutic potential
Han, H. Q., Zhou, X., Mitch, W. E., & Goldberg, A. L. (2013) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2013.05.019 · Cited by 314
Campbell, C., McMillan, H. J., Mah, J. K., Tarnopolsky, M., Selby, K., McClure, T., Wilson, D. M., Sherman, M. L., Escolar, D., & Attie, K. M. (2017) · Muscle & Nerve · doi:10.1002/mus.25268 · Cited by 240
Inhibin at 90: From Discovery to Clinical Application, a Historical Review
Makanji, Y., Zhu, J., Mishra, R., Holmquist, C., Wong, W. P. S., Schwartz, N. B., Mayo, K. E., & Woodruff, T. K. (2014) · Endocrine Reviews · doi:10.1210/er.2014-1003 · Cited by 186
Cited by
Gonzalez-Gil, A. M., & Elizondo-Montemayor, L. (2020) · Nutrients · doi:10.3390/nu12061899 · Cited by 278
Adipokines, Myokines, and Hepatokines: Crosstalk and Metabolic Repercussions
de Oliveira dos Santos, A. R., de Oliveira Zanuso, B., Miola, V. F. B., Barbalho, S. M., Santos Bueno, P. C., Flato, U. A. P., Detregiachi, C. R. P., Buchaim, D. V., Buchaim, R. L., Tofano, R. J., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22052639 · Cited by 189
Perakakis, N., Stefanakis, K., & Mantzoros, C. S. (2020) · Metabolism · doi:10.1016/j.metabol.2020.154320 · Cited by 162
Self-citationStefanakis, K., Kokkorakis, M., & Mantzoros, C. S. (2024) · Metabolism · doi:10.1016/j.metabol.2024.156057 · Cited by 142
Self-citationEmerging pharmacotherapies for obesity: A systematic review
Kokkorakis, M., Chakhtoura, M., Rhayem, C., Al Rifai, J., Ghezzawi, M., Valenzuela-Vallejo, L., & Mantzoros, C. S. (2025) · Pharmacological Reviews · doi:10.1124/pharmrev.123.001045 · Cited by 102
Self-citationMolecular insights of exercise therapy in disease prevention and treatment
Walzik, D., Chirino, T. Y. W., Zimmer, P., & Joisten, N. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01841-0 · Cited by 107
Relative Energy Deficiency in Sport (REDs): Endocrine Manifestations, Pathophysiology and Treatments
Angelidi, A. M., Stefanakis, K., Chou, S. H., Valenzuela-Vallejo, L., Dipla, K., Boutari, C., Ntoskas, K., Tokmakidis, P., Kokkinos, A., Goulis, D. G., et al. (2024) · Endocrine Reviews · doi:10.1210/endrev/bnae011 · Cited by 83
Self-citationEffect of Various Exercise Regimens on Selected Exercise-Induced Cytokines in Healthy People
Domin, R., Dadej, D., Pytka, M., Zybek-Kocik, A., Ruchała, M., & Guzik, P. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph18031261 · Cited by 79
“HIIT2 to ~135% of the basal value.”
BackgroundInfluentialPeradze, N., Farr, O. M., Perakakis, N., Lázaro, I., Sala-Vila, A., & Mantzoros, C. S. (2019) · Cardiovascular Diabetology · doi:10.1186/s12933-019-0945-7 · Cited by 61
Self-citationFollistatins in glucose regulation in healthy and obese individuals
Perakakis, N., Kokkinos, A., Peradze, N., Tentolouris, N., Ghaly, W., Tsilingiris, D., Alexandrou, A., & Mantzoros, C. S. (2019) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.13572 · Cited by 56
Self-citationEffect of exercise intensity on circulating hepatokine concentrations in healthy men
Willis, S. A., Sargeant, J. A., Thackray, A. E., Yates, T., Stensel, D. J., Aithal, G. P., & King, J. A. (2019) · Applied Physiology, Nutrition, and Metabolism · doi:10.1139/apnm-2018-0818 · Cited by 48
Seo, D. Y., Ko, J. R., Jang, J. E., Kim, T. N., Youm, J. B., Kwak, H., Bae, J. H., Kim, A. H., Ko, K. S., Rhee, B. D., et al. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20246284 · Cited by 50
Polyzos, S. A., Perakakis, N., Boutari, C., Kountouras, J., Ghaly, W., Anastasilakis, A. D., Karagiannis, A., & Mantzoros, C. S. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgz172 · Cited by 46
Self-citationConforto, R., Rizzo, V., Russo, R., Mazza, E., Maurotti, S., Pujia, C., Succurro, E., Arturi, F., Ferro, Y., Sciacqua, A., et al. (2024) · Metabolism · doi:10.1016/j.metabol.2024.156052 · Cited by 48
Evidence from clinical studies of leptin: current and future clinical applications in humans
Perakakis, N., & Mantzoros, C. S. (2024) · Metabolism · doi:10.1016/j.metabol.2024.156053 · Cited by 57
Self-citationFollistatin-Like Proteins: Structure, Functions and Biomedical Importance
Parfenova, O. K., Kukes, V. G., & Grishin, D. V. (2021) · Biomedicines · doi:10.3390/biomedicines9080999 · Cited by 49
Zhang, M., Song, Y., Zhu, J., Ding, P., & Chen, N. (2024) · Scientific Reports · doi:10.1038/s41598-024-79506-9 · Cited by 60
Valenzuela‐Vallejo, L., Chrysafi, P., Kouvari, M., Guatibonza-García, V., Mylonakis, S. C., Katsarou, A., Verrastro, O., Markakis, G., Eslam, M., Papatheodoridis, G., et al. (2023) · Metabolism · doi:10.1016/j.metabol.2023.155694 · Cited by 38
Self-citationCirculating Follistatin and Activin A and Their Regulation by Insulin in Obesity and Type 2 Diabetes
Sylow, L., Vind, B. F., Kruse, R., Møller, P. M., Wojtaszewski, J. F. P., Richter, E. A., & Højlund, K. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa090 · Cited by 36
Valenzuela‐Vallejo, L., & Mantzoros, C. S. (2022) · Metabolism · doi:10.1016/j.metabol.2022.155246 · Cited by 34
Self-citationNAFLD, MAFLD, and beyond: one or several acronyms for better comprehension and patient care
Portincasa, P. (2023) · Internal and Emergency Medicine · doi:10.1007/s11739-023-03203-0 · Cited by 35
Shah, A., Dodson, W. C., Kris‐Etherton, P. M., Kunselman, A. R., Stetter, C., Gnatuk, C. L., Estes, S. J., Allison, K. C., Sarwer, D. B., Sluss, P. M., et al. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa682 · Cited by 37
Talotta, R., Porrello, I., Restuccia, R., & Magaudda, L. (2021) · Clinical Rheumatology · doi:10.1007/s10067-021-05954-7 · Cited by 29
Liver fat as risk factor of hepatic and cardiometabolic diseases
Demir, M., Bornstein, S. R., Mantzoros, C. S., & Perakakis, N. (2023) · Obesity Reviews · doi:10.1111/obr.13612 · Cited by 31
Self-citationVinales, K. L., Begaye, B., Thearle, M. S., Krakoff, J. A., & Piaggi, P. (2019) · Metabolism · doi:10.1016/j.metabol.2019.01.016 · Cited by 25
Bouzoni, E., Perakakis, N., & Mantzoros, C. S. (2020) · Metabolism · doi:10.1016/j.metabol.2020.154392 · Cited by 18
Self-citationEndocrine Mechanisms Connecting Exercise to Brown Adipose Tissue Metabolism: a Human Perspective
Méndez-Gutiérrez, A., Osuna‐Prieto, F. J., Aguilera, C. M., Ruiz, J. R., & Sánchez‐Delgado, G. (2020) · Current Diabetes Reports · doi:10.1007/s11892-020-01319-7 · Cited by 19
Barovic, M., Hahn, J. J., Heinrich, A., Adhikari, T., Schwarz, P. E. H., Mirtschink, P., Funk, A. M., Kabisch, S., Pfeiffer, A. F. H., Blüher, M., et al. (2025) · Diabetes Care · doi:10.2337/dc24-1412 · Cited by 20
Self-citationLi, X., Zhang, H., Ma, X., Wang, Y., Han, X., Yang, Y., Yu, H., & Bao, Y. (2022) · Obesity · doi:10.1002/oby.23598 · Cited by 15
Perakakis, N., Kokkinos, A. D., Peradze, N., Tentolouris, N., Ghaly, W., Tsilingiris, D., Alexandrou, A. P., & Mantzoros, C. S. (2020) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3297 · Cited by 15
Self-citationFollistatin and follistatin-like 3 in metabolic disorders
Bielka, W., Przezak, A., & Pawlik, A. (2023) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2023.106785 · Cited by 17
A Decade Later: Revisiting the TGFβ Family’s Role in Diabetes
Brown, M., & Schneyer, A. L. (2020) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2020.11.006 · Cited by 14
Jürimäe, J., Vaiksaar, S., Purge, P., & Tillmann, V. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.689696 · Cited by 16
Lim, J. Y., & Kim, E. (2023) · Metabolites · doi:10.3390/metabo13090979 · Cited by 14
Panagiotou, G., Ghaly, W., Upadhyay, J., Pazaitou‐Panayiotou, K., & Mantzoros, C. S. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab041 · Cited by 11
Self-citationPham, T. C. P., Bojsen-Møller, K. N., Madsbad, S., Wojtaszewski, J. F. P., Richter, E. A., & Sylow, L. (2020) · International Journal of Obesity · doi:10.1038/s41366-020-00664-7 · Cited by 8
Kizer, J. R., Patel, S., Ganz, P., Newman, A. B., Bhasin, S., Lee, S., Cawthon, P. M., LeBrasseur, N. K., Shah, S. J., Psaty, B. M., et al. (2023) · The Journals of Gerontology Series A · doi:10.1093/gerona/glad206 · Cited by 8
Moqaddam, M. A., Nemati, M., Dara, M. M., Hoteit, M., Sadek, Z., Ramezani, A., Rand, M. K., Daloii, A. A., Pashaei, Z., Almaqhawi, A., et al. (2024) · Nutrients · doi:10.3390/nu16172857 · Cited by 6
Synergistic Effects of Protein Intake and Exercise on Biomarkers of Sarcopenia: A Systematic Review
Cruz-Pierard, S., & Jiménez, S. O. I. (2026) · Biomolecules · doi:10.3390/biom16020195 · Cited by 7
Kurose, S., Onishi, K., Miyauchi, T., Takahashi, K., & Kimura, Y. (2023) · Endocrine Research · doi:10.1080/07435800.2023.2253452 · Cited by 4
Ehrlich, S., Licht, L., Kolb, T., Hoffmann, C., Stender, E. M., Tam, F. I., Poitz, D. M., Roessner, V., Bornstein, S. R., & Perakakis, N. (2025) · Molecular Psychiatry · doi:10.1038/s41380-025-03245-0 · Cited by 3
Self-citationResearch developments in metabolism 2018
Peradze, N., Farr, O. M., & Mantzoros, C. S. (2018) · Metabolism · doi:10.1016/j.metabol.2018.11.011 · Cited by 4
Self-citationMcGuire, C. J., Knowles, E. J., Harris, P. A., & Menzies‐Gow, N. J. (2025) · Journal of Equine Veterinary Science · doi:10.1016/j.jevs.2025.105660 · Cited by 2
Effects of weight loss rate on myostatin and follistatin dynamics in patients with obesity
Kurose, S., Onishi, K., Miyauchi, T., Takahashi, K., & Kimura, Y. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1418177 · Cited by 2
Expression and distribution of activin-follistatin-inhibin axis in the urinary bladder
Mao, W., Zhang, T., Chen, H., Barge, S., Wang, Z., Olumi, A. F., Alper, S. L., & Yu, W. (2025) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2025.1519977 · Cited by 1
Cao, W., Gu, Z., Fu, R. G., Chen, Y., He, Y., Rui, Y., Yang, X., & He, Z. (2025) · Genes · doi:10.3390/genes16070810 · Cited by 1
Plasma Activin A and Decorin in Exercised Purebred Arabian Horses – Preliminary Study
Kędzierski, W., Kowalik, S., Mojsym, W., Janczarek, I., & Tkaczyk, E. (2021) · Journal of Equine Veterinary Science · doi:10.1016/j.jevs.2021.103638 · Cited by 1
Babaeinejad, M., Matinhomaee, H., & Fatolahi, H. (2023) · Disease and Diagnosis · doi:10.34172/ddj.2023.496 · Cited by 2
Investigation of cardiovascular risk parameters in adolescents with metabolic syndrome
Can, Ü., Akdu, S., Bağcı, Z., & Büyükinan, M. (2023) · Cardiology in the Young · doi:10.1017/s1047951123001622
Comparison of Muscle Damage Markers and Myokines between Adult and Middle-Aged Marathon Runners
Zocoler, C. A. S., Sierra, A., Lima, G. H. O., Galán, B. S. M., Barbeiro, H. V., de Souza, H. P., & Cury‐Boaventura, M. F. (2025) · OBM Geriatrics · doi:10.21926/obm.geriatr.2501301
The interplay between exosomal miRNAs and cytokine networks in metabolic diseases
Joshi, R., Verma, K., Kapoor, D. U., Saini, V., & Sharma, S. K. (2026) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2026.1731121
Qiao, C., Yang, C., Guo, S., Yang, S., & Wang, Y. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27219657
Metadata
- Authors
- Perakakis, N., Mougios, V., Fatouros, I., Siopi, A., Draganidis, D., Peradze, N., Ghaly, W., & Mantzoros, C. S.
- Affiliations
- Beth Israel Deaconess Medical Center (US)
- Aristotle University of Thessaloniki (GR)
- University of Thessaly (GR)
- Corresponding author
- Mantzoros, Christos S
- ORCID
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2018-08-01
- Volume
- 103
- Issue
- 10
- Pages
- 3890-3899
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- PMC
- PMC6179167
- OpenAlex
- W2885628972
- Cited by
- 52
- References
- 35
- Citations by year
- 2026: 3 · 2025: 6 · 2024: 9 · 2023: 9 · 2022: 2 · 2021: 7 · 2020: 9 · 2019: 5 · 2018: 2
- FWCI
- 2.05
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- University of Thessaly Institutional Repository (University of Thessaly) (submittedVersion)
- Funders
- National Institutes of Health (K24D081913)
- Deutsche Forschungsgemeinschaft (389891681)
- State Scholarships Foundation
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Muscle Physiology and Disorders
- Health Sciences › Medicine › Physiology (medical) › Exercise and Physiological Responses
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Physical Performance
- Keywords
- activin A, activin B, follistatin, FSTL3, exercise response, metabolic syndrome, anthropometric variables, serum lipids, blood pressure, resistance training, high-intensity interval exercise, physical activity
- MeSH terms
- Adolescent, Adult, Aged, Aging, Anthropometry, Body Composition, Humans, Male, Middle Aged, Physical Fitness, Exercise, Activins, Follistatin, Follistatin-Related Proteins, Adiposity, Young Adult, Sedentary Behavior
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.